22 §8737. Rulemaking
§8737. Rulemaking The organization may adopt rules to implement this subchapter. Rules adopted pursuant to this section are major substantive rules as defined in Title 5, chapter 375, subchapter 2‑A. [PL 2019, c. 470, §8 (NEW).] SECTION HISTORY PL 2019, c. 470, §8 (NEW).
22 §8741. International referenced rate pricing
§8741. International referenced rate pricing 1. Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings. A. “Manufacturer” has the same meaning as in section 8731, subsection 3. [PL 2021, c. 606, §1 (NEW).] B. “Prescription drug” has the same meaning as in section 8731, […]
22 §8709. Financial data; scope of service data
§8709. Financial data; scope of service data Financial data and scope of service data must be filed, stored and managed as follows. [PL 1999, c. 353, §15 (AMD).] 1. Financial data. Each health care facility shall file with the organization, in a form specified by rule pursuant to section 8704, financial information including costs […]
22 §8735. Compliance
§8735. Compliance 1. Certification of accuracy. A manufacturer, wholesale drug distributor or pharmacy benefits manager that submits a notification or report to the organization pursuant to this subchapter shall submit with the notification or report a signed written certification of the notification’s or report’s accuracy. [PL 2019, c. 470, §8 (NEW).] 2. Civil penalty. […]
22 §8710. Restructuring data
§8710. Restructuring data Restructuring data must be filed, stored and managed as follows. [PL 1995, c. 653, Pt. A, §2 (NEW); PL 1995, c. 653, Pt. A, §7 (AFF).] 1. Major structural changes. The board may require providers and payors to report the occurrence of major structural changes relevant to the restructuring of the […]
22 §8736. Public report
§8736. Public report Beginning November 1, 2020 and annually thereafter, the organization shall produce and post on its publicly accessible website an annual report, including information developed from the disclosures received pursuant to this subchapter on trends in the cost of prescription drugs, analysis of manufacturer prices and price increases, the major components of prescription […]
22 §8711. Other health care information
§8711. Other health care information 1. Development of health care information systems. In addition to its authority to obtain information to carry out the specific provisions of this chapter, the organization may require providers and payors to furnish information with respect to the nature and quantity of services or coverage provided to the extent necessary […]
22 §8712. Reports
§8712. Reports The organization shall produce clearly labeled and easy-to-understand reports as follows. Unless otherwise specified, the organization shall distribute the reports on a publicly accessible site on the Internet or via mail or e-mail, through the creation of a list of interested parties. The organization shall make reports available to members of the public […]
22 §8713. Confidentiality protection for certain health care practitioners (REPEALED)
§8713. Confidentiality protection for certain health care practitioners (REPEALED) SECTION HISTORY PL 2007, c. 460, §4 (NEW). PL 2011, c. 494, §9 (RP).
22 §8714. General public access to data; rules (WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2013, c. 528, §12)
§8714. General public access to data; rules (CONTAINS TEXT WITH VARYING EFFECTIVE DATES) (WHOLE SECTION TEXT EFFECTIVE ON CONTINGENCY: See PL 2013, c. 528, §12) The board shall adopt rules to provide for public access to data allowed under this chapter and to implement the requirements of this section. [PL 2013, c. 528, §10 […]